PD-1/PD-L1 co-location: A novel biomarker for immunotherapy response in non-small cell lung cancer

Thorac Cancer. 2022 Jun;13(11):1545-1547. doi: 10.1111/1759-7714.14436. Epub 2022 Apr 28.

Authors

Xiayao Diao¹, Chao Guo¹, Shanqing Li¹

Affiliation

¹ Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

No abstract available

Publication types

Editorial
Comment

MeSH terms

B7-H1 Antigen
Biomarkers, Tumor / genetics
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Immunotherapy
Lung Neoplasms* / therapy
Programmed Cell Death 1 Receptor

Substances

B7-H1 Antigen
Biomarkers, Tumor
Programmed Cell Death 1 Receptor